Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile

When does Eli Lilly and Company (LLY) report earnings? On Oct 29, 2026, before the open

None of its last 12 announcements carries a time on the filing, so there is no way to say which session they fell in. Each one comes from the 8-K with item 2.02 that Eli Lilly filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 67 quarters since Jul 22, 2009, and every row links to its filing.

Next announced date: Oct 29, 2026, before the open. It comes from the company through the public Nasdaq calendar, not from the SEC: it is a scheduled date and companies do move it. Everything else on this page already happened, with its filing attached.

Day of the weekThursday7 of 12
After the quarter ends34 daysmedian over the window
Lead over the 10-Q/10-K0 sessionsmedian over the window
Quarters on file67since Jul 22, 2009

The last 20 quarters, one by one

"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For Eli Lilly, a median of 0 sessions over the last 12 quarters, i.e. the same market day.

AnnouncementDayTime (NY)SessionQuarter endedSEC reportLeadFiling
Aug 5, 2026Wednesdayno time on the filingJun 30, 202610-Q · Aug 5, 20260 sessions8-K
Apr 30, 2026Thursdayno time on the filingMar 31, 202610-Q · Apr 30, 20260 sessions8-K
Feb 4, 2026Wednesdayno time on the filingDec 31, 202510-K · Feb 12, 20266 sessions8-K
Oct 30, 2025Thursdayno time on the filingSep 30, 202510-Q · Oct 30, 20250 sessions8-K
Aug 7, 2025Thursdayno time on the filingJun 30, 202510-Q · Aug 7, 20250 sessions8-K
May 1, 2025Thursdayno time on the filingMar 31, 202510-Q · May 1, 20250 sessions8-K
Feb 6, 2025Thursdayno time on the filingDec 31, 202410-K · Feb 19, 20258 sessions8-K
Oct 30, 2024Wednesdayno time on the filingSep 30, 202410-Q · Oct 30, 20240 sessions8-K
Aug 8, 2024Thursdayno time on the filingJun 30, 202410-Q · Aug 8, 20240 sessions8-K
Apr 30, 2024Tuesdayno time on the filingMar 31, 202410-Q · Apr 30, 20240 sessions8-K
Feb 6, 2024Tuesdayno time on the filingDec 31, 202310-K · Feb 21, 202410 sessions8-K
Nov 2, 2023Thursdayno time on the filingSep 30, 202310-Q · Nov 2, 20230 sessions8-K
Aug 8, 2023Tuesdayno time on the filingJun 30, 202310-Q · Aug 8, 20230 sessions8-K
Apr 27, 2023Thursdayno time on the filingMar 31, 202310-Q · Apr 27, 20230 sessions8-K
Feb 2, 2023Thursdayno time on the filingDec 31, 202210-K · Feb 22, 202313 sessions8-K
Nov 1, 2022Tuesdayno time on the filingSep 30, 202210-Q · Nov 1, 20220 sessions8-K
Aug 4, 2022Thursdayno time on the filingJun 30, 202210-Q · Aug 4, 20220 sessions8-K
Apr 28, 2022Thursdayno time on the filingMar 31, 202210-Q · Apr 29, 20221 session8-K
Feb 3, 2022Thursdayno time on the filingDec 31, 202110-K · Feb 23, 202213 sessions8-K
Oct 26, 2021Tuesdayno time on the filingSep 30, 202110-Q · Oct 27, 20211 session8-K

The table shows the 20 most recent quarters. All 67 are in the CSV, with the same columns and one row per quarter.

Download all 67 LLY quarters as CSV → Free, no account.

How Eli Lilly shares moved on their latest earnings

Reported EPS beat the consensus estimate in 5 of the 5 quarters with an estimate.

AnnouncementSessionWindow, close to closeLLYSPYEPS actual / expected
Aug 5, 2026no time on the filingno time: unknown which close caught it8.38 / 6.58 (+27.3%)
Apr 30, 2026no time on the filingno time: unknown which close caught it8.55 / 6.79 (+25.9%)
Feb 4, 2026no time on the filingno time: unknown which close caught it7.54 / 6.91 (+9.1%)
Oct 30, 2025no time on the filingno time: unknown which close caught it7.02 / 5.89 (+19.2%)
Aug 7, 2025no time on the filingno time: unknown which close caught it6.31 / 5.59 (+12.9%)
May 1, 2025no time on the filingno time: unknown which close caught it
Feb 6, 2025no time on the filingno time: unknown which close caught it
Oct 30, 2024no time on the filingno time: unknown which close caught it

Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.

Where each number comes from

From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that Eli Lilly filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. No time is published for this company: its EDGAR acceptance stamp and the official header of its filings disagree, so there is no way to know whether the stamp is in New York time or UTC, and the two readings are four or five hours apart —enough to change session—. The dates are firm; the time and the session are deliberately left empty rather than filled in with a guess.

What this data does not know

  • The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so any 8-K time is an upper bound. The session says which one the news landed in, not what minute it was said.
  • Nothing before Jul 22, 2009: it is Eli Lilly's oldest quarter with announcement and report paired in the file.
  • What will happen. The page's only future date, Oct 29, 2026, was announced by Eli Lilly on the Nasdaq calendar and can be moved.
  • Eli Lilly's identity is its SEC CIK (0000059478), not its symbol: symbols get recycled and renamed.

When other Healthcare companies report earnings

More on Eli Lilly

Eli Lilly is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 14 of 464, and 1 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.

Eli Lilly (LLY) analysis page →

LLY insider buys and sells →

All ~500 S&P 500 companies, sorted by when they report →

Guide: 10-K, 10-Q and 8-K · all guides

What is behind these dates

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Aug 5, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity